SELLAS Life Sciences Group, Inc. (SLS)

SLS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	107.2	71.89	13.99	2.63	17.23	21.46
Cash & Short-Term Investments	107.2	71.89	13.99	2.63	17.23	21.46
Cash Growth	276.17%	414.03%	431.79%	-84.73%	-19.72%	-39.40%
Other Current Assets	3.97	3.32	2.34	0.54	0.53	1.59
Total Current Assets	111.17	75.21	16.33	3.17	17.76	23.04
Net Property, Plant & Equipment	0.84	0.96	0.93	0.86	0.87	0.72
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Long-Term Assets	0.26	0.26	0.27	0.28	0.4	0.59
Total Assets	114.18	78.35	19.43	6.22	20.94	26.28
Accounts Payable	3.63	2.95	3.5	5.64	3.36	2.14
Accrued Expenses	2.26	3.53	5.47	7.65	6.29	2.64
Current Portion of Leases	0.56	0.54	0.54	0.45	0.37	0.2
Other Current Liabilities	-	-	-	-	5.5	-
Total Current Liabilities	6.46	7.02	9.51	13.74	15.52	4.98
Long-Term Leases	0.31	0.46	0.46	0.46	0.57	0.61
Other Long-Term Liabilities	-	-	-	-	0	0.34
Total Long-Term Liabilities	0.31	0.46	0.46	0.46	0.58	0.95
Total Liabilities	6.77	7.47	9.97	14.2	16.09	5.93
Common Stock	0.02	0.02	0.01	0	0	0
Additional Paid-in Capital	390.79	345.84	257.58	209.27	184.75	158.95
Retained Earnings	-283.4	-274.99	-248.13	-217.24	-179.9	-138.6
Shareholders' Equity	107.41	70.87	9.47	-7.98	4.85	20.35
Total Liabilities & Equity	114.18	78.35	19.43	6.22	20.94	26.28
Total Debt	0.87	1	1	0.91	0.95	0.81
Net Cash (Debt)	106.33	70.89	12.99	1.72	16.28	20.65
Net Cash Growth	49.98%	445.95%	653.19%	-89.41%	-21.15%	-40.00%
Net Cash Per Share	0.82	0.65	0.21	0.06	0.84	1.33
Book Value	107.41	70.87	9.47	-7.98	4.85	20.35
Book Value Per Share	0.83	0.65	0.15	-0.29	0.25	1.31
Tangible Book Value	105.5	68.96	7.55	-9.89	2.94	18.43
Tangible Book Value Per Share	0.81	0.63	0.12	-0.36	0.15	1.19

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q